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 Prescription drug coverage and preventive care for seniors will 
improve, but some will see insurance premiums rise. 
 
 
How Will the Patient Protection and Affordable Care Act  
Affect Seniors? 
 
Timely Analysis of Immediate Health Policy Issues  
July 2010  
Robert Berenson and John Holahan 
 
The population over the age of 65 will 
be affected in a number of ways by 
the Patient Protection and Affordable 
Care Act (PPACA) even though the 
law is primarily aimed at non-elderly 
population. There will be increases in 
premiums for high-income people, 
cutbacks in the advantages some 
seniors gain from Medicare 
Advantage plans, and reductions in 
cost-sharing in the prescription drug 
benefit and for preventive services. It 
is likely that the sustainable growth 
rate (SGR) formula will continue to 
be overridden periodically to head off 
major fee cuts but not permanently 
fixed. Therefore physician fees will 
continue to be adjusted upward by 
less than the inflation rate for medical 
practices. There will still be some 
additional efforts to increase primary 
care fees to encourage access in 
Medicare. But increased demand for 
services by the non-elderly who will 
become insured could potentially 
threaten access to care for seniors. 
Reductions in rates for other providers 
such as hospitals and nursing homes 
have been suggested by the Medicare 
Payment Advisory Commission 
(MedPAC) and the Congressional 
Budget Office (CBO) for several 
years and should not adversely affect 
access for Medicare beneficiaries,
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though having them in place for 
several years could lead to significant 
differences between private and 
Medicare rates.
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 There are large 
numbers of provisions that introduce 
new payment and delivery system 
reforms that could either benefit or 
harm access to care for seniors. 
Beneficiary Provisions  
Premiums 
The PPACA threshold for the higher 
income-related Medicare Part B 
premiums ($85,000 for an individual 
and $170,000 for a couple) is frozen 
from 2011 through 2019. Freezing the 
threshold will have the effect of 
making an increasing number of 
people each year subject to the higher 
premiums. This provision provides 
$25.0 billion in revenue.
3
 PPACA also 
reduces the Medicare Part D subsidy 
for those with incomes above $85,000 
(for an individual) and $170,000 (for a 
couple), effective 2011. Reducing the 
Medicare Part D subsidy represents 
savings in the amount of $10.7 billion 
over ten years making this a relatively 
small provision of the bill.
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It is interesting to note that the current 
Medicare premium is $110.50 per 
month and increases to $154.70 per 
month when the $85,000/$170,000 
threshold is reached and continues to 
increase as incomes increase. Those 
eligible for Medicare Savings 
Programs (MSP) will continue to 
receive assistance with premiums up 
to 120 percent of the federal poverty 
level. Individuals with incomes above 
MSP eligibility levels will pay the full 
premium. This amounts to about 10 
percent of income for those just above 
MSP levels. Because premiums do not 
increase with incomes, premiums as a 
share of incomes decline until the 
high-income threshold is reached. 
Thus, low-income seniors with 
incomes above Medicaid or MSP 
eligibility levels will have to pay more 
in Part B as a percentage of income 
than will low-income non-elderly 
individuals under health reform. 
Further, the benefit package seems to 
be at about the level of a 70 percent 
actuarial value plan, or a silver plan, 
under health reform; however, unlike 
the plans offered to the non-elderly, 
there are no out-of-pocket limits. 
Individuals can pay more for more 
comprehensive coverage through 
Medi-gap policies. This is similar to 
buying up to a gold or a platinum plan 
in an exchange. Without 
supplemental coverage, there are 
circumstances in which individuals 
will have to pay more for Medicare 
coverage and obtain less protection 
than it will now be offered to the non-
elderly. 
The Medicare Drug Benefit 
The main enhancement was to phase 
down the beneficiary coinsurance rate 
in the Medicare Part D coverage gap 
from 100 percent to 25 percent by 
2020. This is accomplished by the 
following: For brand drugs, 
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pharmaceutical manufacturers will be 
required to provide a 50 percent 
discount on prescriptions filled in the 
gap beginning in 2011, in addition to 
federal subsidies of 75 percent of 
brand-name drug cost by 2020 
(phased in beginning 2013). There are 
also federal subsidies for generics of 
75 percent in 2020 (phased in 
beginning 2011). The cost-sharing 
reductions save Medicare 
beneficiaries about $43 billion over 
ten years.  
Preventive Services 
The statute also eliminates cost-
sharing for Medicare covered 
preventive services that are 
recommended by the U.S. Preventive 
Services Task Force and waives the 
Medicare deductible for colorectal 
cancer screening. Medicare is 
authorized to cover personalized 
prevention services, including a 
comprehensive health risk assessment 
annually. 
Medicare Advantage Plans 
One of the most significant impacts 
will be on seniors enrolled in 
Medicare Advantage (MA) plans. 
Currently, the federal government 
provides a significant subsidy to MA 
plans (currently about 9 percent more 
than the cost to the plans for providing 
the statutory Medicare benefits, 
assuming SGR-imposed cuts do not 
actually occur). Most of the additional 
payments to plans result in extra 
benefits for MA enrollees, including 
buying down part of standard cost-
sharing, filling in some of the Part D 
doughnut hole, and providing 
particular services, such as eye 
glasses, hearing aids and health club 
memberships. The legislation 
restructures payments to MA plans by 
setting payments to different 
percentages of traditional Medicare 
spending rates as calculated at the 
county level, with higher payments 
for areas with low traditional 
Medicare rates (up to 115 percent) 
and lower payments (as low as 95 
percent) for areas with high traditional 
Medicare rates. Phase-in of the 
revised rates will take place over three 
to six years, depending on area, 
beginning in 2011. There is also 
provision for a pay-for-quality 
enhancement in payments for 
qualifying plans.  
The long phase-out of the 
overpayments and the different 
benchmarks based on traditional 
Medicare spending attempt to mitigate 
the post-BBA 1997 problem of MA 
plans leaving the market and 
significantly reducing extra benefits. 
Different from the late 1990s, there 
are many more MA plans of different 
kinds in all markets to absorb 
beneficiaries whose plan may leave 
the program. Nevertheless, surely the 
extra benefit offerings, now valued at 
over $1,000 per year, will be reduced. 
Low-income seniors above Medicaid 
or MSP eligibility levels have 
disproportionately higher enrollment 
in MA now and will be affected 
directly. At the same time, the 
reductions in the overpayments 
produce about $136 billion of 
Medicare savings and were needed to 
try to establish a more level playing 
field for competition between private 
plans and traditional Medicare. The 
Centers for Medicare and Medicaid 
Services (CMS) Office of the Actuary 
recently estimated that over the 
decade enrollment in MA will drop 
about one-third from the current 24 
percent of all beneficiaries.
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Reduced Provider Payment 
Rates 
Hospitals, Skilled Nursing Facilities 
and Home Health Agencies 
Section 3401 provides broad revisions 
in the approach to setting market 
basket updates for most provider 
categories by incorporating a 
productivity adjustment into the 
update, beginning in various years, 
and implements additional market 
basket reductions for certain 
providers. These legislated reductions 
in market basket updates and other 
changes in provider payments 
represent most of the CBO-scored 
savings in Medicare, while extending 
the projected exhaustion date of the 
Part A trust fund by about a decade. 
These cuts in provider payment rates 
are not expected to have major 
impacts on Medicare beneficiaries 
although that is a possibility in the 
long run. The recent report from CMS 
actuaries argue that the impact of 
sustained reductions in market basket 
updates to reflect productivity gains 
may eventually have adverse effects 
on beneficiaries and on providers.
6
 In 
general, the argument that CBO has 
made is that market basket updates 
overstate cost increases to providers 
because of productivity increases, 
particularly hospitals, therefore 
payments can be cut, though some 
hospitals will need to reduce costs in 
response.
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 In areas where Medicare 
payments are now less than cost, 
MedPAC has argued that this has 
more to do with commercial payments 
being too high rather than Medicare 
payments being too low.
8
 The real 
issue is the effect on providers and in 
turn on beneficiaries if payment 
increases are less than inflation over a 
sustained period of time. At some 
point these could be a serious cause 
for concern. Payments to home health 
agencies and nursing facilities are 
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more than adequate in general but 
there are problems in some areas and 
for some kinds of patients as well. 
Physicians 
For physicians, there is no 
productivity adjustment provision, as 
the sustainable growth rate provision 
which remains in law, provides for 
payment cuts if increases in physician 
expenditures per beneficiaries exceeds 
the growth in gross domestic product. 
Congress annually (or even more 
often) overrides the SGR trigger for 
payment reductions and sets rate 
increases below medical inflation for 
physicians. 
A few other payment changes deserve 
mention. Along with a number of 
provisions designed to increase the 
supply of the health care workforce, 
including establishment of a national 
commission tasked with reviewing 
health care workforce and projected 
workforce needs and creation of a 
Primary Care Extension Program to 
support primary care practices, there 
are a few provisions that could affect 
primary care physicians, partly 
designed to increase the supply of 
physicians able to care for the aging 
population. Specifically, beginning in 
2011, primary care physicians and 
general surgeons practicing in health 
professional shortage areas will 
receive a 10 percent Medicare bonus 
payment for five years. This provision 
represents new spending, with an 
exemption from the usual budget-
neutrality adjustment that affects the 
Medicare Fee Schedule. There is also 
a provision to give the Secretary 
greater authority to identify and adjust 
misvalued codes in the physician fee 
schedule, although CMS lacks the 
resources needed to obtain the data 
necessary for improving the accuracy 
of time estimates that are a core 
component of valuing services. If 
CMS is able to take this on, there 
should be redistribution within the 
budget neutrality provisions toward 
primary care, away from particular 
specialties.  
It should be noted that independent of 
PPACA, CMS has been actively 
attempting to correct some misvalued 
codes, leading to some controversy 
about whether Medicare payments are 
acceptable to physicians. Although 
MedPAC consistently concludes that 
surveys have not shown a spike in 
access problems for beneficiaries 
because of physician non-
participation, there are increasing 
anecdotal reports of physicians, 
especially primary care doctors, not 
accepting new Medicare patients, 
except for “age-ins” from their own 
practices. These various legislative 
provisions and regulatory actions will 
have an impact on physicians’ 
willingness to see Medicare patients 
going forward. These problems of 
access to physicians, particularly 
primary care doctors, will likely be 
worsened by the increased demand for 
services from the newly insured. 
The Independent Payment Advisors 
Board 
The law establishes an Independent 
Payment Advisory Board (IPAB) 
comprised of 15 full-time members to 
submit legislative proposals 
containing recommendations to 
reduce the per capita rate of growth in 
Medicare spending if spending 
exceeds a target growth rate, as 
determined by the CMS Chief 
Actuary. Recommendations from the 
Board to reduce spending could begin 
as early as 2014, although hospitals 
and hospices are exempt from further 
reductions through 2019. The Board’s 
role is carefully circumscribed – its 
jurisdiction is over payment; it is 
prohibited from “rationing” care, 
increasing revenues, and changing 
benefits, eligibility or beneficiary 
cost-sharing. The new Board will 
continue to function alongside of 
MedPAC, which remains advisory to 
Congress. The IPAB also can make 
recommendations for private 
payments, which is important because 
there are limits on how much 
Medicare rates can deviate from the 
private market before access problems 
emerge. But because Congress has no 
jurisdiction over privately negotiated 
rates, such recommendations would 
not have the same force as the IPAB’s 
Medicare payment recommendations 
would have. 
Improving Quality and Health 
System Performance 
PPACA has provisions to test new 
organizational and payment models in 
Medicare, with the view that testing in 
Medicare (and in multi-payer pilots 
and demonstrations) could lead to 
overall health system performance 
improvement. The centerpiece of this 
activity is the establishment of a 
Center for Medicare and Medicaid 
Innovation within CMS. The purpose 
of the Center will be to research, 
develop, test and expand innovative 
payment and delivery arrangements to 
improve quality and reduce costs. 
Successful models can be expanded 
without obtaining new legislative 
authority, and pilots and 
demonstrations need not be budget 
neutral as currently required under 
long-standing Office of Management 
and Budget guidance. The law 
appropriates $10 billion for the 
activities of the Center. 
In addition to the broad authority 
provided to the new Center, specific 
provisions are designed to test 
particular models of innovation 
including: accountable care 
organizations, a national pilot 
program on payment bundling, the 
“independence at home” model of 
geriatric home care and a hospital 
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readmissions reduction program. In 
addition, there are numerous 
provisions designed to increase the 
number and relevance of performance 
measures and simultaneously expand 
the role of pay-for-reporting and pay-
for-performance (the latter initially an 
extension of the current Medicare 
value-based payment program for 
hospitals).  
Most policy analysts think positively 
of the potential of new delivery and 
payment approaches to improve care, 
first, for Medicare beneficiaries, and, 
subsequently, for all patients if 
successful. However, some of the new 
payment and organizational models 
might have implications for 
beneficiaries’ current access to care. 
For example, an ACO might or might 
not have some limitations on freedom 
of choice. In some versions, 
beneficiaries may be assigned to 
ACOs without their knowledge 
because their freedom of choice is not 
affected. Yet, the organization they 
have been assigned to have altered 
financial incentives, which some 
would argue beneficiaries have a right 
to know about. In short, all of these 
payment and value-purchasing 
initiatives may have implications for 
access, cost and quality, which have a 
beneficiary dimension that will 
deserve more attention than received 
thus far.  
 
 
 
 
 
Conclusion 
Seniors will benefit from reductions in 
cost-sharing for the Medicare 
prescription drug benefit and the 
elimination of cost-sharing for 
recommended Medicare covered 
preventive services. However, there 
will be reductions in the benefits some 
seniors now gain from Medicare 
Advantage plans as well as higher 
premiums for higher-income people. 
Provider rate cuts should not 
adversely affect access for Medicare 
beneficiaries, though they could if 
they are left in place indefinitely. 
There are many new payment and 
delivery system reforms that offer 
promise for cost containment and 
most likely benefit seniors but have 
some potential to harm access to care. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Timely Analysis of Immediate Health Policy Issues  5 
Notes 
 
1 Medicare Payment Advisory Commission. 
2008. “Report to Congress: Medicare Payment 
Policy.” Washington, DC: Medicare Payment 
Advisory Commission, March; Congressional 
Budget Office. 2008. “Budget Options: Health 
Care.” Washington, DC: Congressional Budget 
Office, December. 
2 Center for Medicare and Medicaid Services, 
Office of the Actuary. 2010. “Estimated Financial 
Effects of the Patient Protection and Affordable 
Care Act.” Baltimore, MD: Center for Medicare 
and Medicaid Services, April  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Congressional Budget Office. 2010. Letter to 
the Honorable Nancy Pelosi providing estimates 
of the spending and revenue effects of the 
reconciliation proposal. Washington, DC: 
Congressional Budget Office, March 20.  
4 Congressional Budget Office. 2010.  
5 Center for Medicare and Medicaid Services. 
2010.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Center for Medicare and Medicaid Services. 
2010.  
7 Congressional Budget Office. 2008.  
8 Medicare Payment Advisory Commission. 
2008.  
  
Timely Analysis of Immediate Health Policy Issues  6 
The views expressed are those of the authors and should not be attributed to any campaign or to the Robert Wood 
Johnson Foundation, or the Urban Institute, its trustees, or its funders. 
About the Authors and Acknowledgements  
Robert Berenson, M.D., is an institute fellow and John Holahan, Ph.D., is director of the Health Policy Center of the 
Urban Institute. 
This research was funded by the Robert Wood Johnson Foundation. The authors thank Stephen Zuckerman for several 
helpful suggestions. 
About the Urban Institute 
The Urban Institute is a nonprofit, nonpartisan policy research and educational organization that examines the social, 
economic, and governance problems facing the nation. 
About the Robert Wood Johnson Foundation 
The Robert Wood Johnson Foundation focuses on the pressing health and health care issues facing our country. As the 
nation’s largest philanthropy devoted exclusively to improving the health and health care of all Americans, the Foundation 
works with a diverse group of organizations and individuals to identify solutions and achieve comprehensive, meaningful, 
and timely change. For more than 35 years, the Foundation has brought experience, commitment, and a rigorous, balanced 
approach to the problems that affect the health and health care of those it serves. When it comes to helping Americans 
lead healthier lives and get the care they need, the Foundation expects to make a difference in your lifetime. For more 
information, visit www.rwjf.org. 
 
 
 
 
 
